Astellas Pharma Inc (ALPMF)

Astellas Pharma Financial Statements


Astellas Pharma Financial Overview

Astellas Pharma's market cap is currently ―. The company's EPS TTM is $0.555; its P/E ratio is 23.60; Astellas Pharma is scheduled to report earnings on November 3, 2022, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue¥ 303.87B¥ 340.63B¥ 325.52B¥ 326.14B¥ 308.62B
Gross Profit¥ 244.96B¥ 271.27B¥ 263.02B¥ 263.91B¥ 250.29B
EBIT¥ -9.84B¥ 79.62B¥ 54.51B¥ 37.55B¥ -18.31B
EBITDA¥ 11.24B¥ 101.14B¥ 73.45B¥ 55.69B¥ 248.00M
Net Income Common Stockholders¥ -8.41B¥ 60.88B¥ 40.92B¥ 30.69B¥ -12.33B
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments¥ 337.28B¥ 368.09B¥ 328.29B¥ 306.00B¥ 331.69B
Total Assets¥ 2.33T¥ 2.36T¥ 2.26T¥ 2.25T¥ 2.27T
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -337.28B¥ -368.09B¥ -328.29B¥ -306.00B¥ -331.69B
Total Liabilities¥ 872.09B¥ 889.95B¥ 843.89B¥ 866.59B¥ 887.51B
Stockholders Equity¥ 1.46T¥ 1.47T¥ 1.42T¥ 1.38T¥ 1.39T
Cash Flow
Free Cash Flow¥ 31.31B¥ 58.17B¥ 71.34B¥ 20.17B¥ 63.12B
Operating Cash Flow¥ 48.59B¥ 69.47B¥ 99.30B¥ 40.08B¥ 81.70B
Investing Cash Flow¥ -14.83B¥ 8.16B¥ -34.66B¥ -21.09B¥ -14.16B
Financing Cash Flow¥ -75.03B¥ -51.33B¥ -45.21B¥ -44.73B¥ -58.14B
Currency in JPY

Astellas Pharma Earnings and Revenue History

Astellas Pharma Debt to Assets

Astellas Pharma Cash Flow

Astellas Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis